Clinical trial
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD…
NCT00191919 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191919 |
|---|---|
| Title | A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain |
| Official title | A Ten-Week, Randomized, Double-Blind Study Evaluating the Efficacy of Duloxetine 60mg Once Daily Versus Placebo in Outpatients With Major Depressive Disorder and Pain |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | Duloxetine Hydrochloride, Placebo |
| Enrollment | 310 |
| Start date | May 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | Belgium, Czechia, Finland, France, Germany, Slovakia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: